JP2014144959A5 - - Google Patents

Download PDF

Info

Publication number
JP2014144959A5
JP2014144959A5 JP2014040627A JP2014040627A JP2014144959A5 JP 2014144959 A5 JP2014144959 A5 JP 2014144959A5 JP 2014040627 A JP2014040627 A JP 2014040627A JP 2014040627 A JP2014040627 A JP 2014040627A JP 2014144959 A5 JP2014144959 A5 JP 2014144959A5
Authority
JP
Japan
Prior art keywords
test sample
tumor
adam8
control
antibody
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2014040627A
Other languages
English (en)
Japanese (ja)
Other versions
JP2014144959A (ja
Filing date
Publication date
Application filed filed Critical
Publication of JP2014144959A publication Critical patent/JP2014144959A/ja
Publication of JP2014144959A5 publication Critical patent/JP2014144959A5/ja
Pending legal-status Critical Current

Links

JP2014040627A 1999-07-28 2014-03-03 腫瘍治療のための組成物と方法 Pending JP2014144959A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US14621799P 1999-07-28 1999-07-28
US60/146,217 1999-07-28

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2011231764A Division JP5897300B2 (ja) 1999-07-28 2011-10-21 腫瘍治療のための組成物と方法

Publications (2)

Publication Number Publication Date
JP2014144959A JP2014144959A (ja) 2014-08-14
JP2014144959A5 true JP2014144959A5 (enExample) 2015-01-29

Family

ID=22516336

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2001513995A Withdrawn JP2003508028A (ja) 1999-07-28 2000-07-27 腫瘍治療のための組成物と方法
JP2011231764A Expired - Lifetime JP5897300B2 (ja) 1999-07-28 2011-10-21 腫瘍治療のための組成物と方法
JP2014040627A Pending JP2014144959A (ja) 1999-07-28 2014-03-03 腫瘍治療のための組成物と方法

Family Applications Before (2)

Application Number Title Priority Date Filing Date
JP2001513995A Withdrawn JP2003508028A (ja) 1999-07-28 2000-07-27 腫瘍治療のための組成物と方法
JP2011231764A Expired - Lifetime JP5897300B2 (ja) 1999-07-28 2011-10-21 腫瘍治療のための組成物と方法

Country Status (9)

Country Link
US (2) US7226596B2 (enExample)
EP (1) EP1204682B1 (enExample)
JP (3) JP2003508028A (enExample)
AT (1) ATE488529T1 (enExample)
AU (1) AU776600B2 (enExample)
CA (1) CA2378182C (enExample)
DE (1) DE60045247D1 (enExample)
ES (1) ES2355055T3 (enExample)
WO (1) WO2001009189A2 (enExample)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2378182C (en) * 1999-07-28 2014-09-23 Genentech, Inc. Compositions and methods for the treatment of tumors
US7157567B2 (en) 2002-02-20 2007-01-02 Astellas Pharma, Inc. Polypeptide
CN101586155A (zh) * 2002-09-30 2009-11-25 肿瘤疗法科学股份有限公司 非小细胞肺癌的诊断方法
US20080014594A1 (en) * 2003-01-31 2008-01-17 Kevin Hestir Lung-Expressed Polypeptides
EP1730533A1 (en) * 2004-03-24 2006-12-13 Oncotherapy Science, Inc. Adam8 as tumor marker and therapeutic target for non-small cell lung cancer
ES2318575T3 (es) * 2004-11-10 2009-05-01 Novartis Vaccines And Diagnostics, Inc. Interferon beta desamidado.
FR2879462B1 (fr) * 2004-12-21 2008-12-26 Sod Conseils Rech Applic Utilisation de toxine botulique pour une insensibilisation locale prolongee
KR20070100307A (ko) 2004-12-22 2007-10-10 제넨테크, 인크. 가용성 다중 막관통 단백질의 생산 방법
US20060242012A1 (en) * 2005-04-22 2006-10-26 Sumit Agarwal Determining or scoring properties to solicit to join ad network using advertiser or aggregated advertiser interest
AU2007336243B2 (en) 2006-12-19 2012-07-26 Ablynx N.V. Amino acid sequences directed against a metalloproteinase from the ADAM family and polypeptides comprising the same for the treatment of ADAM-related diseases and disorders
US20090304719A1 (en) 2007-08-22 2009-12-10 Patrick Daugherty Activatable binding polypeptides and methods of identification and use thereof
GB2453589A (en) 2007-10-12 2009-04-15 King S College London Protease inhibition
MX2010005811A (es) * 2007-11-27 2010-06-09 Veridex Llc Enumeracion automatica y caracterizacion de las celulas del melanoma circulantes en la sangre.
WO2010081173A2 (en) * 2009-01-12 2010-07-15 Cytomx Therapeutics, Llc Modified antibody compositions, methods of making and using thereof
US8399219B2 (en) 2009-02-23 2013-03-19 Cytomx Therapeutics, Inc. Protease activatable interferon alpha proprotein
WO2014186364A2 (en) * 2013-05-13 2014-11-20 Tufts University Methods and compositions for prognosis, diagnosis and treatment of adam8-expressing cancer
TW201613622A (en) * 2014-10-14 2016-04-16 Bionet Corp Composition for skincare and pharmaceutical composition and preparation method thereof
TW201613621A (en) * 2014-10-14 2016-04-16 Bionet Corp Composition for promoting growth of dermal papilla cells, pharmaceutical composition, and preparation method thereof
JP2018130113A (ja) * 2017-02-15 2018-08-23 国立大学法人 東京大学 慢性骨髄性白血病（ｃｍｌ）の検査方法及び検査用キット、チロシンキナーゼ阻害剤（ｔｋｉ）耐性ｃｍｌの単離方法、並びにｃｍｌにおけるｔｋｉ耐性の低減剤及びそのスクリーニング方法
AU2020283906A1 (en) * 2019-05-31 2022-01-20 Trustees Of Tufts College Anti-ADAM8 antibodies and uses of the same

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH04187084A (ja) * 1990-11-22 1992-07-03 Otsuka Pharmaceut Co Ltd 単球表面に発現する抗原及び該抗原に対するモノクローナル抗体
DK0822186T3 (da) * 1994-01-20 2000-06-26 British Biotech Pharm L-tert-leucin-2-pyridylamid
GB9608130D0 (en) 1996-04-19 1996-06-26 Univ Sheffield Adam proteins and uses thereof
ATE244579T1 (de) * 1997-01-22 2003-07-15 Univ Texas Verfahren und zusammensetzungen des gewebefaktors zur koagulation und behandlung von tumoren
GB9705521D0 (en) * 1997-03-18 1997-05-07 Univ Sheffield The use of mononuclear phagocytes in the vivo imaging of hypoxic/ischaemic tissue
US5922566A (en) * 1997-05-13 1999-07-13 Incyte Pharmaceuticals, Inc. Tumor-associated antigen
GB2339200B (en) * 1998-06-06 2001-09-12 Genostic Pharma Ltd Genostics
WO2000040749A2 (en) * 1999-01-06 2000-07-13 Genenews Inc. Method for the detection of gene transcripts in blood and uses thereof
US20010034023A1 (en) * 1999-04-26 2001-10-25 Stanton Vincent P. Gene sequence variations with utility in determining the treatment of disease, in genes relating to drug processing
CA2378182C (en) * 1999-07-28 2014-09-23 Genentech, Inc. Compositions and methods for the treatment of tumors
EP1259595B1 (en) * 2000-02-25 2007-04-04 Immunex Corporation Integrin antagonists
ES2264440T3 (es) * 2000-03-24 2007-01-01 Micromet Ag Amplificacion de mrna.
US6458552B1 (en) * 2000-06-06 2002-10-01 Ortho-Mcneil Pharmaceutical, Inc. Metalloprotease peptide substrates and methods
AU2002213005A1 (en) * 2000-10-02 2002-04-15 Board Of Regents, The University Of Texas System Method of detection and interpretation of mutations through expression or function tests of haploid genes
AU2002230997A1 (en) * 2000-12-15 2002-06-24 Genetics Institute, Llc Methods and compositions for diagnosing and treating rheumatoid arthritis
WO2002085285A2 (en) * 2001-04-18 2002-10-31 Wyeth Methods and reagents for regulating bone and cartilage formation
US20030138792A1 (en) * 2001-05-31 2003-07-24 Millennium Pharmaceuticals, Inc. Compositions, kits, and methods for identification, assessment, prevention and therapy of cervical cancer
AU2002318944A1 (en) * 2001-08-01 2003-02-17 Coley Pharmaceutical Gmbh Methods and compositions relating to plasmacytoid dendritic cells
US20030148334A1 (en) * 2001-10-12 2003-08-07 Zairen Sun Differentially-expressed genes and polypeptides in angiogenesis
EP1527196A4 (en) * 2002-03-01 2007-03-14 Childrens Hosp Medical Center TREATMENT OF ASTHMA AND ALLERGIES
US20040018522A1 (en) * 2002-05-09 2004-01-29 Brigham And Women's Hospital, Inc. Identification of dysregulated genes in patients with multiple sclerosis
US20050003390A1 (en) * 2002-05-17 2005-01-06 Axenovich Sergey A. Targets for controlling cellular growth and for diagnostic methods
JP2004041121A (ja) * 2002-07-12 2004-02-12 Hitachi Ltd アレルギー解析方法及びシステム
US7482117B2 (en) * 2002-12-20 2009-01-27 Celera Corporation Genetic polymorphisms associated with myocardial infarction, methods of detection and uses thereof
EP1613269B1 (en) * 2003-04-04 2015-02-25 Incyte Corporation Compositions, methods and kits relating to her-2 cleavage
US20050009067A1 (en) * 2003-05-19 2005-01-13 Craig Logsdon Expression profile of pancreatic cancer
US20050059101A1 (en) * 2003-09-10 2005-03-17 Gordon Ringold Bivalent targeting of cell surfaces

Similar Documents

Publication Publication Date Title
Harouaka et al. Circulating tumor cells: advances in isolation and analysis, and challenges for clinical applications
JP2016500110A5 (enExample)
Tu et al. Luminescent biodetection based on lanthanide-doped inorganic nanoprobes
Alegre et al. Circulating biomarkers in malignant melanoma
MX2020001156A (es) Metodo para el pronostico y tratamiento de metastasis de cancer.
MX361058B (es) Método para detectar células tumorales circulantes 5t4-positivas y métodos de diagnóstico de cáncer 5t4-positivo en un sujeto mamífero.
Leung et al. Ovarian cancer biomarkers: current state and future implications from high-throughput technologies
EA201792497A1 (ru) Антитела к gitr для диагностики злокачественной опухоли
RU2015125575A (ru) Композиции и способы для лечения злокачественной опухоли
WO2015094995A3 (en) Gene signature biomarkers of tumor response to pd-1 antagonists
JP2016507233A5 (enExample)
WO2013033629A3 (en) Methods and compositions for the treatment and diagnosis of colorectal cancer
WO2015094996A3 (en) Pd-l1 gene signature biomarkers of tumor response to pd-1 antagonists
WO2018007872A9 (en) Biomarkers for inflammatory bowel disease
WO2015077382A3 (en) Combined cytology and molecular testing for early detection of esophageal adenocarcinoma
WO2014028862A9 (en) Use of dna in circulating exosomes as a diagnostic marker for metastasic disease
EP2619587A4 (en) BIOMARKER FOR PREDICTING THE REPRODUCTION OF A COLORECTAL CARCINOMA
WO2015082416A8 (en) Novel rna-biomarkers for diagnosis of prostate cancer
Gao et al. Effects of miR-16 plus CA19-9 detections on pancreatic cancer diagnostic performance
PH12017500798A1 (en) Pna probes, kits and methods for detecting human papillomavirus genotypes of human papillomavirus
WO2015023503A3 (en) Compositions and methods for multimodal analysis of cmet nucleic acids
ES2877689T3 (es) miARN circulantes como marcador de detección temprana y marcador pronóstico
JP2014501929A5 (enExample)
Lopez-Munoz et al. Markers of circulating breast cancer cells
WO2019089858A3 (en) Methods of assessing or monitoring a response to a cell therapy